GlobalData on MSN7d
Xgene’s non-opioid analgesic reduces pain in Phase IIb trial
A trial with XG005 met it's primary and secondary endpoints, demonstrating a statistically significant reduction in ...
Business Wire9d
A Novel Non-Opioid Multimodal Analgesic from Xgene Pharmaceutical Reduces Pain and a Need for Opioid Consumption in a Post-Surgical Pain Trial
Treatment with XG005 resulted in statistically significant and clinically meaningful reduction in post-surgical pain ...
Morningstar9d
A Novel Non-Opioid Multimodal Analgesic from Xgene Pharmaceutical Reduces Pain and a Need for Opioid Consumption in a Post-Surgical Pain Trial
“I have not seen any analgesics showing such great efficacy ... “There is a substantial need for more efficacious, safer, non-opioid treatment for acute pain, as many patients are unable ...
News Medical on MSN3d
Non-Opioid Pain Relievers Beat Opioids After Dental Surgery
Results in The Journal of American Dental Association showed the non-opioid combination provided superior pain relief during ...
Yahoo Finance10d
A Novel Non-Opioid Multimodal Analgesic from Xgene Pharmaceutical Reduces Pain and a Need for Opioid Consumption in a Post-Surgical Pain Trial
For those patients who required rescue analgesics, XG005 increased the time to first use of rescue by 8-fold and it reduced the total amount of opiate consumption medication by 4-fold in a high dose ...
Eagle-Tribune10d
A Novel Non-Opioid Multimodal Analgesic from Xgene Pharmaceutical Reduces Pain and a Need for Opioid Consumption in a Post-Surgical Pain Trial
Xgene Pharmaceutical announced additional insights into the positive results of a multiple-center, placebo-controlled, dose-ranging Phase 2b study (registration number: NCT06017999) in patients ...